Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For Pharmaceuticals Under An Open-house Model For The Active Ingredient Certolizumab Pegol. Certolizumab Pegol 2026-02-21
Germany Medicines With The Active Ingredient Eltrombopag (atc 2026-02-22
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V By An Open House Model To The Active Ingredient Omalizumab (atccode According To Who 2026-02-22
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V By Way Of An Open House Model To The Active Ingredient Brinzolamide/brimonidin (official Atcode 2026-02-22
Germany Medicines With The Active Ingredient Rivaroxaban (atc: B01af01 - In All Power Strengths Except 2.5 Mg Each Divided Oral Dosage Form) 2026-02-22
Germany Medicines With The Active Substance Rivaroxaban (atc: B01af01 - In All Active Strengths Except 2.5 Mg Per Divided Oral Form) 2026-02-22
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V In The Way Of An Open House Model To The Active Ingredient Certolizumab Pegol (atccode According To Who 2026-02-22
Thailand Purchase Of A Blood Coagulation Meter (activated Clotting Time Analyzer) 2026-02-22
Germany Medicines Contracts With Accession Option 2026-02-23
Germany Openhouser Discount Contracts 202511 Eltrombopag 2026-02-23
Whats app